Good news for CMT 1A and 1B

Published on January 7th, 2020

InFlectis BioScience Announces Successful Completion of Phase 1 Clinical Trial of Oral IFB-088

For more informations, follow the link: https://bit.ly/2QNzl9W

or visit InFlectis BioScience web site: http://www.inflectisbioscience.com/

To read latest news